Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights May 15, 2024
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation May 14, 2024
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights May 13, 2024
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference May 13, 2024
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates May 10, 2024
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024 May 07, 2024
